LD-2 disclosure · 4th Quarter - Report
VERTEX PHARMACEUTICALS INCORPORATED
Client
- Location
- Massachusetts · United States of America
Registrant
- Description
- Global biotechnology company
- Location
- Boston, Massachusetts, United States of America
Lobbying activities
7 issuesHealth Issues
Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments.
LobbyistsMATTHEW O SCHUMAKER · SWARNA VALLURUPALLI · ms HANNAH BETH CORNWELL · ms KRISTIN RICHTER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals.
LobbyistsMATTHEW O SCHUMAKER · SWARNA VALLURUPALLI · ms HANNAH BETH CORNWELL · ms KRISTIN RICHTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Congressional Budget Office (CBO) · Vice President of the U.S. · White House Office · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Taxation/Internal Revenue Code